Smart niosomes of temozolomide for enhancement of brain targeting
Drug delivery to the brain is challenging because of the low permeability of blood–brain barrier, and therefore, optimum concentration of chemotherapeutics in the target area specifically for glioblastoma, an aggressive brain tumor, opens a new path of research. To achieve the goal, the oral alkylat...
Main Authors: | Anindita De, Nagasamy Venkatesh, M Senthil, Bharat Kumar Reddy Sanapalli, R Shanmugham, Veera Venkata Satyanarayana Reddy Karri |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-10-01
|
Series: | Nanobiomedicine |
Online Access: | https://doi.org/10.1177/1849543518805355 |
Similar Items
-
Preclinical models of diabetic wound healing: A critical review
by: Bharat Kumar Reddy Sanapalli, et al.
Published: (2021-10-01) -
Ameliorating the antitumor activity of lenalidomide using PLGA nanoparticles for the treatment of multiple myeloma
by: Veera Venkata Satyanarayana Reddy Karri, et al.
Published: (2017-06-01) -
Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain Targeting
by: Marco Bragagni, et al.
Published: (2012-02-01) -
Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles
by: Xin-Hua Tian, et al.
Published: (2011-02-01) -
PEGylation of Niosomes
by: Elliott, John A.
Published: (2009)